|
Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with …
MarketWatch (press release) Boehringer Ingelheim announced that a comprehensive confirmatory Phase III trial program named UniTinA-asthma(TM) is ongoing to fully evaluate the potential of the long-acting bronchodilator in the treatment of asthma in pediatric, adolescent and adult … Boehringer Ingelheim Announces Positive Phase II Results for Once-Daily … Results of Phase II Study of Boehringer Ingelheim's Investigational … |
View full post on asthma – Google News